Common Side Effects of Lipitor and Crestor
Lipitor (atorvastatin) and Crestor (rosuvastatin), both statins, share similar side effect profiles due to their cholesterol-lowering mechanism, which involves HMG-CoA reductase inhibition. Muscle pain (myalgia) tops the list for both, affecting 1-10% of users. Headaches, nausea, diarrhea, and joint pain also occur frequently with either drug.[1][2]
Lipitor reports slightly higher rates of digestive issues like constipation (up to 5%) and dyspepsia (3-5%), while Crestor edges out with more reports of weakness or fatigue (2-5%). Liver enzyme elevations (ALT/AST >3x upper limit) happen in under 1% for both, but require monitoring.[3]
How Serious Risks Stack Up
Both carry black-box warnings for muscle breakdown (rhabdomyolysis), though incidence is rare (<0.1%). Crestor has a marginally higher risk, especially at doses over 20mg or in Asians due to genetic factors reducing metabolism—FDA adjusted dosing in 2005.[4] Diabetes risk increases with high-intensity statins like these; meta-analyses show 9-12% relative risk rise, comparable between them.[5]
Kidney issues or memory problems are infrequent and not clearly differentiated in head-to-head trials.
Head-to-Head Trial Data
The 2005 STELLAR trial (n=2,400+) found myalgia rates of 4.6% for rosuvastatin 10mg vs. 5.1% for atorvastatin 10mg—statistically similar. Pooled data from LUNAR and other studies confirm no major differences in discontinuation rates (2-4% for both due to side effects).[6][7] Patient forums like Drugs.com reviews echo this: Lipitor scores 5.5/10, Crestor 5.6/10, with muscle complaints dominant.
Factors Influencing Side Effects
Dose matters—higher doses amplify risks for both (e.g., Crestor 40mg doubles myopathy odds vs. Lipitor 80mg).[8] Drug interactions boost concerns: both interact with gemfibrozil (rhabdo risk jumps 10x), but Crestor needs more caution with cyclosporine. Age over 65 or hypothyroidism heightens vulnerability equally.
Switching statins often resolves intolerance; 70% of myalgia patients tolerate another like rosuvastatin if atorvastatin fails.[9]
Who Might Tolerate One Better
No clear winner—choice hinges on efficacy needs (Crestor stronger LDL drop) and genetics. CYP3A4 poor metabolizers fare worse on Lipitor; SLCO1B1 variants hit Crestor harder. Consult a doctor for personalized risk via tools like the FDA statin label comparators.[1][2]
Sources
[1] Lipitor Prescribing Information (FDA)
[2] Crestor Prescribing Information (FDA)
[3] Drugs.com - Atorvastatin Side Effects
[4] FDA Crestor Asian Dosing Update
[5] Lancet Meta-Analysis on Statins and Diabetes (2019)
[6] STELLAR Trial (JAMA, 2005)
[7] LUNAR Trial Data (Am J Cardiol, 2008)
[8] NEJM Statin Safety Review (2013)
[9] Mayo Clinic Statin Intolerance Guidelines